Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
32.49M
Cash
32.35M
Avg Qtr Burn
-6.617M
Short % of Float
1.51%
Insider Ownership
6.12%
Institutional Own.
70.48%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Oxylanthanum Carbonate (OLC) Details Hyperphosphatemia, Chronic kidney disease | PDUFA Approval decision | |
UNI-494 Details Acute Kidney Injury, Kidney disease | Phase 1 Update |